Labcorp Holdings Inc

자세한 내용은 Labcorp Holdings Inc 회사

Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.

회사 정보

종목 코드 LH

회사 이름Labcorp Holdings Inc

상장일Apr 24, 1991

설립일2024

CEOMr. Adam H. Schechter

직원 수70000

유형Ordinary Share

회계 연도 종료Apr 24

주소358 S Main St

도시BURLINGTON

증권 거래소NYSE Consolidated

국가United States of America

우편 번호27215

전화13362291127

웹사이트https://www.labcorp.com/

종목 코드 LH

상장일Apr 24, 1991

설립일2024

회사 임원

이름

이름/직위

직위

주식 보유

변동

Mr. Adam H. Schechter

Chairman of the Board, President, Chief Executive Officer

98.96K

-5.81%

Dr. Brian J. Caveney, M.D., J.D.

Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer

30.07K

-6.24%

Mr. Lance V. Berberian

Executive Vice President - Special Advisor, Strategy

22.53K

+9.59%

Mr. Peter M. Neupert

Independent Director

12.89K

--

Dr. Garheng Kong, M.D., Ph.D.

Lead Independent Director

12.84K

--

Ms. Kerrii B. Anderson, CPA

Independent Director

12.17K

-3.95%

Ms. Richelle P. Parham

Independent Director

9.48K

--

Ms. Amy B. Summy

Executive Vice President, Chief Marketing Officer

5.30K

+16.66%

Mr. Mark S. Schroeder

Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer

4.96K

--

Mr. Akinbolade Oyegunwa

Executive Vice President and Chief Information and Technology Officer

3.46K

+16.48%

이름

이름/직위

직위

주식 보유

변동

Mr. Adam H. Schechter

Chairman of the Board, President, Chief Executive Officer

98.96K

-5.81%

Dr. Brian J. Caveney, M.D., J.D.

Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer

30.07K

-6.24%

Mr. Lance V. Berberian

Executive Vice President - Special Advisor, Strategy

22.53K

+9.59%

Mr. Peter M. Neupert

Independent Director

12.89K

--

Dr. Garheng Kong, M.D., Ph.D.

Lead Independent Director

12.84K

--

Ms. Kerrii B. Anderson, CPA

Independent Director

12.17K

-3.95%

수익 분석

통화: USD마지막 업데이트: Wed, Mar 12

FY2021

FY2020

FY2019

데이터 없음

지역별USD

이름

수익

비율

Northern America

13.09B

81.22%

Europe

2.05B

12.72%

Other Countries

976.40M

6.06%

사업별

지역별

데이터 없음

주식 보유 통계

마지막 업데이트: Fri, May 16

주주

주주 유형

주주

비율

The Vanguard Group, Inc.

11.57%

BlackRock Institutional Trust Company, N.A.

5.50%

State Street Global Advisors (US)

4.57%

Select Equity Group, L.P.

2.65%

Geode Capital Management, L.L.C.

2.47%

Other

73.23%

주주

비율

The Vanguard Group, Inc.

11.57%

BlackRock Institutional Trust Company, N.A.

5.50%

State Street Global Advisors (US)

4.57%

Select Equity Group, L.P.

2.65%

Geode Capital Management, L.L.C.

2.47%

Other

73.23%

주주 유형

주주

비율

Investment Advisor/Hedge Fund

45.40%

Investment Advisor

41.37%

Research Firm

3.23%

Pension Fund

2.08%

Hedge Fund

1.82%

Bank and Trust

1.44%

Sovereign Wealth Fund

1.31%

Individual Investor

0.39%

Insurance Company

0.06%

Other

2.90%

기관 주식 보유

마지막 업데이트: Tue, Jul 1

보고 기간

기관 수

보유 주식

비율

변동

2025Q2

1797

81.29M

97.12%

-4.89M

2025Q1

1872

81.69M

97.58%

-5.17M

2024Q4

1872

81.10M

96.90%

-5.32M

2024Q3

1856

80.09M

95.55%

-6.82M

2024Q2

1876

81.29M

96.43%

-7.49M

2024Q1

1904

82.39M

97.73%

-8.65M

2023Q4

1947

83.11M

99.02%

-9.76M

2023Q3

1930

84.34M

99.29%

-7.18M

2023Q2

1934

84.05M

94.75%

-3.56M

2023Q1

1940

82.33M

92.89%

-5.93M

주주 활동

이름

보유 주식

비율

변동

Chg %

날짜

The Vanguard Group, Inc.

9.69M

11.57%

+71.11K

+0.74%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

4.61M

5.5%

+61.07K

+1.34%

Mar 31, 2025

State Street Global Advisors (US)

3.83M

4.57%

+123.43K

+3.33%

Mar 31, 2025

Select Equity Group, L.P.

2.22M

2.65%

+624.10K

+39.11%

Mar 31, 2025

Geode Capital Management, L.L.C.

2.07M

2.47%

+64.83K

+3.24%

Mar 31, 2025

Allspring Global Investments, LLC

1.96M

2.34%

+40.81K

+2.13%

Mar 31, 2025

Diamond Hill Capital Management Inc.

1.95M

2.33%

-15.51K

-0.79%

Mar 31, 2025

BlackRock Financial Management, Inc.

1.85M

2.21%

-72.89K

-3.79%

Mar 31, 2025

Nordea Funds Oy

1.43M

1.71%

+374.30K

+35.55%

Mar 31, 2025

Fidelity Management & Research Company LLC

1.30M

1.56%

+88.25K

+7.26%

Mar 31, 2025

관련 ETF

마지막 업데이트: Sun, Jul 6

이름

비율

iShares U.S. Healthcare Providers ETF

3.59%

Knowledge Leaders Developed World ETF

2.89%

iShares Large Cap Value Active ETF

2.38%

Thrivent Small-Mid Cap ESG ETF

2.24%

Strategas Global Policy Opportunities ETF

2.11%

SPDR S&P Health Care Services ETF

2.03%

iShares Health Innovation Active ETF

1.93%

Invesco S&P 500 Equal Weight Health Care ETF

1.81%

Brandes US Value ETF

1.61%

First Trust Health Care Alphadex Fund

1.48%

iShares U.S. Healthcare Providers ETF

비율3.59%

Knowledge Leaders Developed World ETF

비율2.89%

iShares Large Cap Value Active ETF

비율2.38%

Thrivent Small-Mid Cap ESG ETF

비율2.24%

Strategas Global Policy Opportunities ETF

비율2.11%

SPDR S&P Health Care Services ETF

비율2.03%

iShares Health Innovation Active ETF

비율1.93%

Invesco S&P 500 Equal Weight Health Care ETF

비율1.81%

Brandes US Value ETF

비율1.61%

First Trust Health Care Alphadex Fund

비율1.48%

주식 배당금

지난 5년 동안 총 692.30M USD의 배당금이 분배되었습니다.

날짜

배당금

기준일

지급일

배당락일

Jan 09, 2025

LH.NB Interim Cash Dividend of gross USD 0.72 paid on Mar 12, 2025 going ex on Feb 27, 2025

Feb 27, 2025

Mar 12, 2025

Feb 27, 2025

Oct 10, 2024

LH.NB Final Cash Dividend of gross USD 0.72 paid on Dec 13, 2024 going ex on Nov 26, 2024

Nov 26, 2024

Dec 13, 2024

Nov 26, 2024

Jul 25, 2024

LH.NB Interim Cash Dividend of gross USD 0.72 paid on Sep 13, 2024 going ex on Aug 29, 2024

Aug 29, 2024

Sep 13, 2024

Aug 29, 2024

Apr 11, 2024

LH.NB Interim Cash Dividend of gross USD 0.72 paid on Jun 12, 2024 going ex on May 24, 2024

May 28, 2024

Jun 12, 2024

May 24, 2024

Jan 12, 2024

LH.NB Interim Cash Dividend of gross USD 0.72 paid on Mar 13, 2024 going ex on Feb 26, 2024

Feb 27, 2024

Mar 13, 2024

Feb 26, 2024

Oct 12, 2023

LH.NB Final Cash Dividend of gross USD 0.72 paid on Dec 12, 2023 going ex on Nov 07, 2023

Nov 08, 2023

Dec 12, 2023

Nov 07, 2023

Jul 13, 2023

LH.NB Interim Cash Dividend of gross USD 0.72 paid on Sep 08, 2023 going ex on Aug 07, 2023

Aug 08, 2023

Sep 08, 2023

Aug 07, 2023

Apr 06, 2023

LH.NB Interim Cash Dividend of gross USD 0.72 paid on Jun 08, 2023 going ex on May 17, 2023

May 18, 2023

Jun 08, 2023

May 17, 2023

Jan 12, 2023

LH.NB Interim Cash Dividend of gross USD 0.72 paid on Mar 13, 2023 going ex on Feb 22, 2023

Feb 23, 2023

Mar 13, 2023

Feb 22, 2023

Oct 12, 2022

LH.NB Final Cash Dividend of gross USD 0.72 paid on Dec 09, 2022 going ex on Nov 16, 2022

Nov 17, 2022

Dec 09, 2022

Nov 16, 2022

주식 분할

날짜

유형

비율

데이터 없음

날짜

유형

비율

데이터 없음

257.877USD

Labcorp Holdings Inc

257.877

개요

회사